Neumora Therapeutics, Inc. Common Stock ( NMRA) - Key Metrics
NMRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.23 | -$0.21 | -$0.21 |
| 2026Q1 | $0 | -$0.30 | -$0.26 | -$0.26 |
| 2025Q4 | $0 | -$0.36 | -$0.29 | -$0.29 |
| 2025Q3 | $0 | -$0.35 | -$0.29 | -$0.29 |
| 2025Q2 | $0 | -$0.33 | -$0.32 | -$0.32 |
NMRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.85 |
| 2026Q1 | 0% | -1.63 |
| 2025Q4 | 0% | -1.28 |
| 2025Q3 | 0% | -1.30 |
| 2025Q2 | 0% | -0.56 |
NMRA
Price: $1.51
52 week price:
Earnings Per Share: -1.23 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 308.1 million